Evercore ISI Group analyst Elizabeth Anderson maintains Align Tech (NASDAQ:ALGN) with a Outperform and raises the price target from $230 to $375.
iBio Further Expands Tech Stack With ShieldTx; Enhances Immuno-Oncology Development Pipeline With Conditionally Activated MUC16xCD3 Bispecific
- ShieldTx potentially increases safety and developability of therapeutic antibodies for difficult targets and modes of action - BRYAN, Texas and SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO)